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ABSTRACT 
It is evident that proper screening procedures prior blood transfusion is a  cost-effective approach for  prevention and 
control of transfusion-transmissible infections (TTIs). Also, it has been documented that sub-standard test kits are mostly 
used in resource limited settings for transfusion related diagnosis. However, the role of such practice in epidemiology of 
transfusion transmissible  viral  infections  in a  tertiary health care facility would give  an insight  to the rates of  blood 
transfusion associated viral transmission in the community at large. Therefore, the study was designed to determine the 
prevalence of Human Immunodeficiency Virus (HIV), Hepatitis B and Hepatitis C viruses among blood donors in a tertiary 
hospital where quality diagnostic procedures are considered prior recruitment of donors. Post ethical approval, counselled 
and consenting 507(M= 426; F=81) aged 19 to 68 years (Median age:39) potential blood donors were recruited and tested for 
HIV,  HBsAg  and  anti-HCV  using  commercial  ELISA  testkit  in  strict  compliance  with  the  manufacturer’sprocedures. 
Overall results show rates of 2.0%, 5.9% and 1.4% for HIV, HBsAg and HCV respectively. Also, highest prevalence rates 
were recorded among age group 26 to 35 years as 2.6%, 7.2% and 2.1% for HIV, HBV and HCV respectively. Furthermore, 
higher  prevalences  rates  were  noted  among  unmarried  individuals  as  2.6%,  6.8%  and  2.1%  for  HIV,  HBV  and  HCV 
respectively. 
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INTRODUCTION 
The  most  common  diseases  transmitted  in  blood 
transfusions are viral infections. Transfusion- 
transmissible infectious agents such as human 
immunodeficiency virus  (HIV),  hepatitis  B  virus 
(HBV) and hepatitis C virus (HCV) are among the 
greatest threats to blood safety for the recipient. The 
discovery of transfusion-transmissible infections 
(TTIs) has heralded a new era in blood transfusion 
practice worldwide with emphasis on two 
fundamental objectives, safety and protection of 
human life [1]. Human immunodeficiency virus 
(HIV), hepatitis B virus (HBV) and hepatitis C virus 
(HCV) are of great concern as transfusion- 
transmissible infections because of their prolonged 
viraemia and carrier or latent state. They also cause 
fatal, acute, chronic and life-threatening disorders. 
Blood transfusion accounts for 5-10% of HIV 
infections   in   sub-Saharan  Africa   [2].   Similarly, 
12.5% of patients who received blood transfusion 
are  at  risk of  post-transfusion hepatitis [3]. 
Therefore, this study was carried out to determine 
the   seroprevalence,  among   selected   group   and 
trends  of  HIV,  HBV and  HCV  among  donors  at 
University College Teaching Hospital in Ibadan 
Nigeria. 
 
MATERIALS AND METHODS 
Study Centre 
The Study centre was located in Ibadan, Oyo State, 
situated in  the  tropical  belt of  Southern Western 
part of Nigeria. The study is at the Blood Bank of 
University College Hospital, Ibadan, Nigeria. 
Study Population 
 
The study participants were potential blood donors 
presenting at the blood bank of the University 
College  Hospital,  Ibadan  between  February  and 
July 2010. Total of Five hundred and seven samples 
was collected from the prospective donors. 
Sample Collection (Blood) 
Samples    were    collected    in    a    tube    without 
anticoagulant. A tourniquet was firmly tied to the 
upper arm of the donor while sitting and skin 
sterilizer with 70% alcohol. The sterile needle was 
inserted into conspicuous antecubital vein and the 
plunger of the sterile syringe was withdrawn and 
pressure applied to the puncture site with a cotton 
wool to stop bleeding. Blood sample was spun on a 
bench centrifuge at 3,000rpm for 10 minutes to 
obtain serum. Serum or plasma was separated 
immediately. 
Data Collection and Laboratory Methods 
A  survey of  the blood sample of  the prospective 
donors  at   the   Blood  Bank,   University  College 
Hospital (UCH) Ibadan was conducted between 
February –   July   2010   using   structured 
questionnaire. Descriptive statistics and correlation 
analysis was performed to  check the  relationship 
between   the   data   and   laboratory   test   results 
observed and inference was drawn using an 




A cross-sectional study was conducted from 
February to July, 2010 at blood bank of the 
University  College  Hospital,  (UCH)  Ibadan.  The 
total  samples  included  all  the  donors,  presented 
and consented to participate during the study 
period. Prior to blood collection, the blood donors 
were   required   to   answer   questionnaire.   After 
consent was obtained and pre-test counselling was 
done, and the questionnaire was completed. 5mls of 
blood sample was collected in sterile tubes without 
anticoagulant from each study participant using a 
vacutainer needle. Serological examination was 
conducted on each sample. 
Serum samples were tested as follows:   for HIV 1 
and HIV 2 using BIO-RAD GenscreenELISA made 
in France; for HBsAg using BIO- RAD monolisa 
ultramade in France; for HCV-AbDIA.PRO ELISA 




Table 1 shows prevalence of HbsAg, HIV and HCV 
antibody  in  the  study  population.  Out  of  507 
participants whose sera were tested using ELISA, 30 
(5.9%) were positive for HbsAg, 7(1.4%) for HCV 
and 10 (2.0%) for HIV.The highest prevalence of 
HBsAg (7.2%)  was found  in  persons  whose  ages 
were between 26-35 years as shown in Table 4. The 
prevalence of HbsAg in theother age groups was as 
follows; 16-25 years (6.6%), 36-45 years (4.2%), 46-55 
years (4.7%). 
The prevalence of HbsAg in age group 26-35 years 
was significantly higher than the other age groups. 
The difference observed in the prevalence of HbsAg 
among different age group, was not statistically 
significant P > 0.05. 
 
 
TABLE 1: PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG), HEPATITIS C (HCV) AND 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AMONG THE STUDY PARTICIPANTS. 
 
Virus Total  NoTested Seropositive 
%              No 
HbsAg 507 5.9 30 
HCV 507 1.4 7 
HIV 507 2.0 10 
 
 
TABLE 2:PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG), HEPATITIS C (HCV) AND 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIBODIES AMONG DIFFERENT 
AGE GROUPOF STUDY PARTICIPANT 
 











HBsAg 9(6.6) 14(7.2) 5(4.2) 2(4.7) 30(6.0) 
HCV Positive 2(1.5) 4(2.1) 1(0.8) 0(.0) 7(1.4) 




TABLE 3:PREVALENCE OF HEPATITIS B SURFACE ANTIGEN (HBSAG), HEPATITIS C (HCV) AND 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIBODIES AMONG THE MARRIED AND 
UNMARRIED PARTICIPANTS 
 
Marital Status No Tested HbsAg 
No (%) Positive 
HCV 
No (%) Positive 
HIV 
No (%) Positive 
Married 297 17(5.7) 3(1.0) 4(1.3) 
Unmarried 192 13(6.8) 4(2.1) 5(2.6) 
Total 489 30(6.1) 7(1.4) 9(1.8) 
 
The results of tests for HCV antibody in the study 
population is shown in Table 1. Out of the 507 sera 
tested for antibody to HCV 7(1.4%) were positive. 
The age distribution of HCV antibody test result in 
the study is shown in Table 4. The highest 
prevalence of HCV antibody (2.1%) was found in 
26-35 years age group. Prevalence of HCV antibody 
in the other age groups are as follows; 16-25 years 
(1.5%) and 36-45 years (0.8%). 
Out  of  507  study  participants  (individual  blood 
donors) whose sera were tested for HIV antibody 10 
(2%) were positive. The age distribution of HIV 
antibody in  this  study is  shown in  Table  2.  The 
highest prevalence of HIV antibody (2.6%) was 
found in 26-35 years age group. Prevalence of HIV 
antibodies in the other age groups was as follows; 
16-25  years  (1.5%),  36-45  (1.7%)  and  46-55  years 
(2.3%). There was no significant difference between 
prevalence  of  HIV  antibody  among  the  different 
age groups, P > 0.05. 
A  total  of  489  study  participants  with  different 
marital status were tested for HbsAg and antibodies 
to HCV and HIV. The prevalence of HbsAg, HCV 
and HIV antibody in married and unmarried 
participants is shown in Table 3. Out of 297 married 




sera, 3(1.0%) and 4(1.3%) were positive of HCV and 
HIV antibodies respectively .Out of 192 unmarried, 
13(6.8%)  were  positive  for  HbsAg,  4(2.1%)  and 
5(2.6%) were positive for HCV and HIV antibodies 
respectively. The prevalence of  HbsAg, and HCV 
antibody was higher among the unmarried 
participants than in married individuals, the 
difference is statistically significant P > 0.05. 
Prevalence of HIV antibody among the unmarried 
was higher than married. There was a statistical 
significance (P < 0.05) difference between HIV 






Blood  transfusion  is  the  process  of  transferring 
blood  or  blood-based  products  from  one  person 
into circulatory system of another, to save lives in 
some medical conditions. Although blood 
transfusion saves million of  lives worldwide each 
year, recipients of the blood or blood product 
transfusions  stand  the  risk  of  becoming  infected 
with blood-borne diseases such as human 
immunodeficiency virus  (HIV),  hepatitis  B  virus 
(HBV) and hepatitis C virus (HCV), through 
transfusion of  infected blood and blood products 
[4].The discovery that HIV, HBV and HCV could be 
transmitted by  blood  transfusion has  provoked a 
greatly heightened emphasis on two fundamental 
objectives, safety and protection of human life [5]. 
Transfusion  transmissible  infections  (TTIs)  are  a 
very serious complication of blood transfusion [6]. 
These infections continue to pose a great challenge 
to transfusion medicine, most especially in Africa, 
due to a high transfusion demand [7]. Hepatitis B 
and  C  viruses  and  HIV  are  distinct,  but  share a 
similar mode of transmission, primarily; through 
unscreened and contaminated blood and blood 
products by contact or transfusion. Other routes 
include sexual intercourse and vertical transmission 
from mother to foetus in the immediate pre-natal 
period [8,9]. 
Prevention  of   transfusion  transmitted  infections 
(TTIs) in developed countries has been achieved by 
reducing unnecessary blood transfusionand 
exclusion of donors with specific risk of viral 
infections.By  contrast,  in  many  developing 
countries, none of these interventions is applied 
uniformly and the risk of (TTIs) remains high. The 
high incidence and prevalence of (TTIs) in the blood 
donors in developing countries means that,  some 
agents escape laboratory detection,[10]. 
In  this  study 507  donors were recruited into  the 
study with ages ranging from age 16 years to 68 
years. In general blood donors must fulfil certain 
requirements, one of which is the age requirement 
of  between  18  –  60  years.  This  explains why  no 
study subject was below age 19 and only a few were 
above 60 years old. There was a predominance of 
males   among   the   study   participants   because 
females are not encouraged to donate blood in 
Nigeria society. Also, most of the replacement 
donors are men. Prevalence of HbsAg (6.8%) and 
antibody to HCV (2.1%) in this study was 
significantly higher among the unmarried 
participants than in married individuals. The 
prevalence of HIV antibody in unmarried was 
higher than the married. Higher prevalence values 
for HbsAg, HCV and HIV antibody in unmarried 
may be due to the fact that the unmarried 
individuals are more likely to engage in behaviours 
that put them at risk of all these infections than the 
married participants. 
The findings of this study showed that hepatitis B 
and C  viruses and HIV are circulating in  Ibadan 
and infecting the residents of the city, including the 
blood donors. Hepatitis B surface antigen, HCV and 
HIV antibodies found were 5.9%, 1.4%, and 2.0%, 
respectively. The result of this study on the 
prevalence of HbsAg in blood donors in UCH, 
Ibadan  isdifferent from  that  ofOlaleye,  et  al.,[11], 
which  showed a  very  high  prevalence (30.8%)  of 
HbsAg in Ibadan. The prevalence HbsAg in blood 
donors in Ibadan is also lower than that found by 
Okerengwo  and  Mudasiru[12],  when  they  tested 
sera  of   blood  donors  for  HbsAg  in  the  same 
location,  this  may  be  due  to  the  awareness  and 
effect of HIV control programmes in the society, for 
the fact that they share the same route of 
transmission.The seroprevalence of  HCV antibody 
found among blood donors in this study is lower 
than that reported by previous workers. Fashola, et 
al.,[13] showed the prevalence of HCV antibody 
among blood donors in UCH, Ibadan was 4.96%. 
Studies carried out in other location in Nigeria also 
showed a  higher prevalence of  HCV  antibody in 
blood donors than that found in the present study. 
Isa, et al.,[14] found HCV antibody prevalence of 
1.8% among blood donors in Kaduna, Kaduna state, 
Nigeria. Studies carried out by Egah, et al., [15] in 
Jos, Plateau state, Nigeria showed that the 
prevalence of HCV antibody among blood donors 
was 6%. Chukwurah, et al.,[16] and Ayolabi, et 
al.,[17] also found higher prevalence of HCV 
antibody among blood donors. A study carried out 
in South-Eastern state of Nigeria, Chukwurah, et al., 
[16] found that 7.6% of blood donors had HCV 
antibody in their sera. In similar study carried out 
in Lagos, Nigeria Ayolabi, et al.,[17] reported that 
8.4%  of   blood  donors  were  positive  for  HCV 
antibody. 
Marked variation in the prevalence of HIV antibody 
of HIV antibody has been reported in different part 
of Nigeria. Some workers have reported prevalence 
of HIV to be lower than the 2% found in this study, 
while others reported higher prevalence of HIV 
antibody from some locations [18, 19,13]. Ejele, et 
al., [18] found that 4% of blood donors in Port 
Harcourt, South-Southern Nigeria had HIV 
antibody. 
Overall, the prevalence of HbsAg, HCV and HIV 






ever reported  from   Nigeria.  This   observation 
may probably be due to the positive impact of 
HIV education and public enlightenment 
campaign which  have  been  in  place  in  Ibadan 
and   everywhere  for   many  years   and   which 
helped in reducing the spread of HIV in Nigeria. 
Since HIV, HCV and HBV have similar modes of 
transmission, the reduction in prevalence of HIV 
infection in  the  community will  also  lead  to  a 
reduction   in   HBV   and   HCV   transmission. 
Another factor that may account for the low 
prevalence of HbsAg, HCV and HIV antibody is 
donor recruitment. Infections by these three 
viruses are more common in commercial and 
replacement donors than voluntary donors. It is 
possible that most of the donors whose sera were 
tested in this study were voluntary donors. 
Age   distribution  of   HbsAg,   HCV   and   HIV 
revealed that there was no significant difference 
in  the  prevalences  of  HbsAg,  HCV  and  HIV 
antibody  among  the  different  age  groups  of 
blood donors. Youths aged 21-30 constituted the 
highest number of HIV and hepatitis B infection, 
HBV  had  21,  {1.4%}  seropsitivity;  HIV  had15 
{1.0%}seropisitivity and age 31-40 had 1 (0.1%) 
for HCV. 
Results of the study which showed that the 
prevalence of HbsAg, HCV and HIV antibody is 
5.9%,  1.4%  and  2.0%  suggest  that  these  three 
major  transfusion  transmissible  viral  infections 
are  still  causing  considerable morbidity in  the 
communities and continue to pose a major 
challenge for blood safety. It seems that the 
prevalence of these viral infections is lower than 
that was reported by previous workers. This 
suggests that the disease control measures of the 
Federal government of Nigeria and Non- 
governmental organizations (NGO) are making a 
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